Crinetics | News & Events

PRESS RELEASES

Press Release | January 2, 2018

Crinetics Pharmaceuticals to Present at J.P. Morgan Healthcare Conference

Press Release | November 14, 2017

Crinetics CEO Talks with Pituitary World News About the Importance of Patient Advocacy in Developing New Medicines

Press Release | October 26, 2017

Crinetics Pharmaceuticals Initiates Phase 1 Study of Lead Candidate CRN00808 for Acromegaly

Press Release | September 6, 2017

Crinetics Pharmaceuticals Awarded Two SBIR Grants to Develop New Therapeutics for Congenital Hyperinsulinism and Cushing’s Disease

Press Release | July 13, 2017

Crinetics Pharmaceuticals Awarded $2.8 Million SBIR Grant to Support Development of Acromegaly Drug Candidate CRN00808

Press Release | November 10, 2016

Crinetics Pharmaceuticals Appoints Anne Klibanski, M.D. to Scientific Advisory Board

Press Release | June 6, 2016

Crinetics Pharmaceuticals Appoints Ajay Madan as Vice President, Development

Press Release | November 2, 2015

The San Diego Union-Tribune: Crinetics raises $40 Million

Press Release | November 2, 2015

Crinetics Pharmaceuticals Completes $40 Million Series A Financing

Press Release | April 27, 2015

Crinetics Pharmaceuticals Appoints Matt Fust, M.B.A., David Clemons, M.D., and John Wallen, Ph.D., J.D. as Corporate, Clinical, and Legal Advisers

23 / 24

Transforming Endocrine Disease Treatment

Be the first to know about the advances we're making in endocrine-rooted care.

Email Signup